Literature DB >> 9606094

Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

R A Gupta, R N DuBois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9606094     DOI： 10.1016/s0016-5085(98)70330-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  19 in total

1.  Gastrin as an autocrine growth factor in colorectal carcinoma: implications for therapy.

Authors:  Graham S Baldwin; Arthur Shulkes
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

2.  Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model.

Authors:  Swati Chandra; Ariel C Nymeyer; Photini Faith Rice; Eugene W Gerner; Jennifer K Barton
Journal:  Cancer Prev Res (Phila)       Date:  2017-06-13

3.  Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells.

Authors:  Gangadhara Reddy Sareddy; Divya Kesanakurti; Puligurtha Bharadhwaja Kirti; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2013-09-08       Impact factor: 3.996

4.  Low endogenous prostaglandin E2 predisposes to relapsing inflammation in experimental rat enterocolitis.

Authors:  H M Kandil; R A Argenzio; R B Sartor
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

5.  Low endogenous prostaglandin E2 predisposes to relapsing inflammation in experimental rat enterocolitis.

Authors:  H M Kandil; R A Argenzio; R B Sartor
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

6.  The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.

Authors:  Gangadhara Reddy Sareddy; Khamushavalli Geeviman; Chinta Ramulu; Phanithi Prakash Babu
Journal:  J Neurooncol       Date:  2011-08-17       Impact factor: 4.130

Review 7.  5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.

Authors:  Yang Cheng; Pierre Desreumaux
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

8.  Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.

Authors:  R A Gupta; J Tan; W F Krause; M W Geraci; T M Willson; S K Dey; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells.

Authors:  Takaaki Inaba; Hajime Sano; Yutaka Kawahito; Timothy Hla; Kaoru Akita; Munetoyo Toda; Ikuo Yamashina; Mizue Inoue; Hiroshi Nakada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-21       Impact factor: 11.205

10.  The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.

Authors:  Amy Hua; Gerardo G Mackenzie; Basil Rigas
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.